WallStSmart

CBIZ Inc (CBZ)vsCintas Corporation (CTAS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cintas Corporation generates 307% more annual revenue ($11.26B vs $2.77B). CTAS leads profitability with a 17.7% profit margin vs 5.6%. CBZ appears more attractively valued with a PEG of 1.04. CBZ earns a higher WallStSmart Score of 70/100 (B).

CBZ

Strong Buy

70

out of 100

Grade: B

Growth: 8.0Profit: 6.5Value: 6.7Quality: 5.0
Piotroski: 5/9Altman Z: 1.52

CTAS

Buy

60

out of 100

Grade: C

Growth: 6.7Profit: 9.0Value: 2.7Quality: 6.5
Piotroski: 5/9Altman Z: 4.33
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CBZUndervalued (+12.4%)

Margin of Safety

+12.4%

Fair Value

$34.79

Current Price

$54.90

$20.11 discount

UndervaluedFair: $34.79Overvalued
CTASSignificantly Overvalued (-35.5%)

Margin of Safety

-35.5%

Fair Value

$147.90

Current Price

$216.53

$68.63 premium

UndervaluedFair: $147.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CBZ4 strengths · Avg: 8.0/10
P/E RatioValuation
16.6x8/10

Attractively priced relative to earnings

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

Operating MarginProfitability
25.6%8/10

Strong operational efficiency at 25.6%

EPS GrowthGrowth
37.7%8/10

Earnings expanding 37.7% YoY

CTAS4 strengths · Avg: 9.3/10
Return on EquityProfitability
38.9%10/10

Every $100 of equity generates 39 in profit

Altman Z-ScoreHealth
4.3310/10

Safe zone — low bankruptcy risk

Market CapQuality
$80.57B9/10

Large-cap with strong market position

Operating MarginProfitability
23.6%8/10

Strong operational efficiency at 23.6%

Areas to Watch

CBZ4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.3%4/10

1.3% revenue growth

Altman Z-ScoreHealth
1.524/10

Distress zone — elevated risk

Profit MarginProfitability
5.6%3/10

5.6% margin — thin

Debt/EquityHealth
1.053/10

Elevated debt levels

CTAS3 concerns · Avg: 2.7/10
Price/BookValuation
16.9x4/10

Trading at 16.9x book value

PEG RatioValuation
3.182/10

Expensive relative to growth rate

P/E RatioValuation
41.0x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : CBZ

The strongest argument for CBZ centers on P/E Ratio, Price/Book, Operating Margin. PEG of 1.04 suggests the stock is reasonably priced for its growth.

Bull Case : CTAS

The strongest argument for CTAS centers on Return on Equity, Altman Z-Score, Market Cap. Profitability is solid with margins at 17.7% and operating margin at 23.6%.

Bear Case : CBZ

The primary concerns for CBZ are Revenue Growth, Altman Z-Score, Profit Margin.

Bear Case : CTAS

The primary concerns for CTAS are Price/Book, PEG Ratio, P/E Ratio. A P/E of 41.0x leaves little room for execution misses.

Key Dynamics to Monitor

CBZ profiles as a value stock while CTAS is a mature play — different risk/reward profiles.

CBZ carries more volatility with a beta of 0.99 — expect wider price swings.

CTAS is growing revenue faster at 8.9% — sustainability is the question.

CTAS generates stronger free cash flow (613M), providing more financial flexibility.

Bottom Line

CBZ scores higher overall (70/100 vs 60/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CBIZ Inc

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

CBIZ, Inc. provides financial, insurance and advisory services in the United States and Canada. The company is headquartered in Cleveland, Ohio.

Cintas Corporation

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Cintas Corporation is an American corporation headquartered in Cincinnati, Ohio, which provides a range of products and services to businesses including uniforms, mats, mops, cleaning and restroom supplies, first aid and safety products, fire extinguishers and testing, and safety courses.

Want to dig deeper into these stocks?